Glucose-dependent Insulinotropic Polypeptide Receptor Agonist

Name
Glucose-dependent Insulinotropic Polypeptide Receptor Agonist
Accession Number
DBCAT005844
Description

Not Available

Drugs
DrugDrug Description
TirzepatideA dual GIP and GLP-1 receptor agonist used for the treatment of type II diabetes in adults as an adjunct to diet and exercise.
Drugs & Drug Targets
DrugTargetType
TirzepatideGlucagon-like peptide 1 receptortarget
TirzepatideGastric inhibitory polypeptidetarget
TirzepatideSerum albumincarrier